Detalhe da pesquisa
1.
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Cell;
184(5): 1281-1298.e26, 2021 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33592174
2.
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Cell;
178(4): 835-849.e21, 2019 08 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31327527
3.
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
Cell;
157(3): 580-94, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24726434
4.
The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.
J Neurooncol;
166(1): 59-71, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38146046
5.
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of 11C-methionine in IDH-mutant astrocytoma.
J Neurooncol;
2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38557927
6.
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Acta Neuropathol;
146(3): 515-525, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37524847
7.
Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.
J Neurooncol;
161(2): 267-275, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36329368
8.
Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
J Neurooncol;
161(2): 193-202, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35612696
9.
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Stem Cells;
39(6): 707-722, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33586320
10.
Implications of IDH mutations on immunotherapeutic strategies for malignant glioma.
Neurosurg Focus;
52(2): E6, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35104795
11.
Genotype-targeted local therapy of glioma.
Proc Natl Acad Sci U S A;
115(36): E8388-E8394, 2018 09 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30082399
12.
Long-term outcomes of multimodality management for parasagittal meningiomas.
J Neurooncol;
147(2): 441-450, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32088814
13.
Chimeric oncolytic adenovirus to break away from neutralizing antibodies.
Mol Ther;
32(4): 875-877, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38513645
14.
Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
Proc Natl Acad Sci U S A;
114(30): E6157-E6165, 2017 07 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28710334
15.
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
J Virol;
92(15)2018 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29793956
16.
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
Proc Natl Acad Sci U S A;
113(16): 4476-81, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27044098
17.
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.
Acta Neuropathol;
136(5): 779-792, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30123936
18.
Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center.
J Neurooncol;
140(3): 639-647, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30209689
19.
Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
Int J Cancer;
141(8): 1671-1681, 2017 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28567859
20.
Blockade of transforming growth factor-ß signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Int J Cancer;
141(11): 2348-2358, 2017 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28801914